Spiradoline mesylate U-62066 mesylate,99.95%

产品编号:Bellancom-124959| CAS NO:87173-97-5| 分子式:C23H34Cl2N2O5S| 分子量:521.50

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-124959
350.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Spiradoline mesylate U-62066 mesylate

产品介绍 Spiradoline mesylate (U-62066 mesylate) 是一种芳基乙酰胺,是一种选择性 kappa 阿片受体 (κ-opioid receptor, KOR) 激动剂,在豚鼠中的 Ki 为 8.6 nM。Spiradoline mesylate 对 μ 和 δ 受体的 Ki 值分别为 252 nM 和 9400 nM。Spiradoline mesylate 具有强效的利尿,止痛,抗心律失常,镇咳,神经保护作用,并易于穿过血脑屏障。
生物活性

Spiradoline mesylate (U-62066 mesylate), an arylacetamide, is a selective kappa opioid receptor (KOR) agonist with a Ki of 8.6 nM in guinea pig. The Ki values of Spiradoline mesylate for μ and δ receptors are 252 nM and 9400 nM, respectively. Spiradoline mesylate has potent diuretic, analgesic, antiarrythmic, antitussive, neuroprotective properties and easily penetrates the blood-brain barrier.

体外研究

Using the patch-clamp method in isolated rat cardiac myocytes, indicated that Spiradoline mesylate (15 to 500 μM) produces its antiarrythmic effect via blockade of sodium channels (and at the higher doses also of potassium currents) in myocardial tissue. Thus, Spiradoline mesylate reduces the peak sodium current, increased the decay rate of the transient outward potassium current, and reduced the sustained plateau potassium amplitude.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Spiradoline mesylate (U-62066; 0.1-0.4 mg/kg; subcutaneous injection; once; Sprague-Dawley rats) treatment dose-dependently reduces social behaviors in non-stressed adults, producing social avoidance at the highest dose tested, while younger animals displays reduced sensitivity to this socially suppressing effect of Spiradoline mesylate. In stressed animals, the socially suppressing effects of the Spiradoline mesylate are blunted at all ages, with juveniles and adolescents exhibiting increased social preference in response to certain doses of U-62066.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Juvenile, adolescent and adult Sprague-Dawley male and female rats exposured to repeated restraint
Dosage: 0.1 mg/kg, 0.2 mg/kg, 0.3 mg/kg, and 0.4 mg/kg
Administration: Subcutaneous injection; once
Result: Dose-dependently reduced social behaviors in non-stressed adults, producing social avoidance at the highest dose tested.
体内研究

Spiradoline mesylate (U-62066; 0.1-0.4 mg/kg; subcutaneous injection; once; Sprague-Dawley rats) treatment dose-dependently reduces social behaviors in non-stressed adults, producing social avoidance at the highest dose tested, while younger animals displays reduced sensitivity to this socially suppressing effect of Spiradoline mesylate. In stressed animals, the socially suppressing effects of the Spiradoline mesylate are blunted at all ages, with juveniles and adolescents exhibiting increased social preference in response to certain doses of U-62066.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Juvenile, adolescent and adult Sprague-Dawley male and female rats exposured to repeated restraint
Dosage: 0.1 mg/kg, 0.2 mg/kg, 0.3 mg/kg, and 0.4 mg/kg
Administration: Subcutaneous injection; once
Result: Dose-dependently reduced social behaviors in non-stressed adults, producing social avoidance at the highest dose tested.
性状Solid
溶解性数据
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服